Sanghilan, Roberto .

HRN: 27-70-09  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/25/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/25/2025
08/31/2025
IV
500mg
Q8h
Acute Pancreatitis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines